Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo

Introduction: Acute intermittent porphyria is a disease inherited in an autosomal dominant manner, occurring with a frequency of 1:75,000 people. The main symptom of the disease is paroxysmal, colicky abdominal pain, which is accompanied by neuropsychiatric symptoms. For some patients, psychiatr...

Full description

Saved in:
Bibliographic Details
Main Authors: Waldemar Kosiba, Dominika Prystacka-Szar, Jakub Siemko, Wojciech Kupczak
Format: Article
Language:English
Published: Kazimierz Wielki University 2025-02-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/57663
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823865188182392832
author Waldemar Kosiba
Dominika Prystacka-Szar
Jakub Siemko
Wojciech Kupczak
author_facet Waldemar Kosiba
Dominika Prystacka-Szar
Jakub Siemko
Wojciech Kupczak
author_sort Waldemar Kosiba
collection DOAJ
description Introduction: Acute intermittent porphyria is a disease inherited in an autosomal dominant manner, occurring with a frequency of 1:75,000 people. The main symptom of the disease is paroxysmal, colicky abdominal pain, which is accompanied by neuropsychiatric symptoms. For some patients, psychiatric symptoms are the only symptom of the disease. In this paper, the case of a 43-year-old patient struggling with recurrent colicky abdominal pain and depressive and anxiety disorders, which intensify during exacerbation periods, is presented, featuring an ambiguous diagnosis of porphyria in previous laboratory tests. In the treatment, glucose infusions, morphine, psychiatric and psychological therapy were used - saline solution was administered as a placebo. Aim:  The aim of this paper is to highlight the difficulties in diagnosing psychiatric symptoms during an acute attack of porphyria, which significantly complicate its treatment, and to consider the possibility of using placebo as one of the elements in the diagnostic and therapeutic plan in order to optimize treatment and avoid complications by using smaller doses of narcotic drugs. Review methods:  A thorough analysis of research studies available on PUBMED was conducted using the following keywords: acute intermittent porphyria; porphobilinogen; depression; anxiety disorders; psychiatry; placebo. The medical history of a 43-year-old female patient, suspected of having acute intermittent porphyria due to recurrent abdominal pain and psychiatric symptoms, was also analyzed. Conclusion:  Our case illustrates how psychiatric symptoms can complicate the diagnosis of acute intermittent porphyria. Failing to recognize acute porphyria also carries the risk of life-threatening complications and may lead to unnecessary pharmacotherapy and stigmatization as a mental illness.  This case demonstrates that placebo can be one of the components of a diagnostic and therapeutic plan of acute intermittent porphyria.
format Article
id doaj-art-0f9aba50924b474083f7aed5951d9bf5
institution Kabale University
issn 2391-8306
language English
publishDate 2025-02-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-0f9aba50924b474083f7aed5951d9bf52025-02-08T08:18:28ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-02-017810.12775/JEHS.2025.78.57663Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using PlaceboWaldemar Kosiba0https://orcid.org/0000-0002-2760-5080Dominika Prystacka-Szar1https://orcid.org/0009-0003-6533-4247Jakub Siemko2https://orcid.org/0009-0009-9318-9458Wojciech Kupczak3https://orcid.org/0009-0002-2620-27382nd Internal Branch with Cardiology Care, Zeromski Hospital, Krakow, PolandLudwik Rydygier Memorial Specialized Hospital in Krakow, PolandLudwika Błażka Provincial Multi-Specialist Hospital in Inowrocław, Poland St. Poznańska 97, 88-100 Inowrocław5th Military Clinical Hospital with SPZOZ Polyclinic in Krakow, Poland Introduction: Acute intermittent porphyria is a disease inherited in an autosomal dominant manner, occurring with a frequency of 1:75,000 people. The main symptom of the disease is paroxysmal, colicky abdominal pain, which is accompanied by neuropsychiatric symptoms. For some patients, psychiatric symptoms are the only symptom of the disease. In this paper, the case of a 43-year-old patient struggling with recurrent colicky abdominal pain and depressive and anxiety disorders, which intensify during exacerbation periods, is presented, featuring an ambiguous diagnosis of porphyria in previous laboratory tests. In the treatment, glucose infusions, morphine, psychiatric and psychological therapy were used - saline solution was administered as a placebo. Aim:  The aim of this paper is to highlight the difficulties in diagnosing psychiatric symptoms during an acute attack of porphyria, which significantly complicate its treatment, and to consider the possibility of using placebo as one of the elements in the diagnostic and therapeutic plan in order to optimize treatment and avoid complications by using smaller doses of narcotic drugs. Review methods:  A thorough analysis of research studies available on PUBMED was conducted using the following keywords: acute intermittent porphyria; porphobilinogen; depression; anxiety disorders; psychiatry; placebo. The medical history of a 43-year-old female patient, suspected of having acute intermittent porphyria due to recurrent abdominal pain and psychiatric symptoms, was also analyzed. Conclusion:  Our case illustrates how psychiatric symptoms can complicate the diagnosis of acute intermittent porphyria. Failing to recognize acute porphyria also carries the risk of life-threatening complications and may lead to unnecessary pharmacotherapy and stigmatization as a mental illness.  This case demonstrates that placebo can be one of the components of a diagnostic and therapeutic plan of acute intermittent porphyria. https://apcz.umk.pl/JEHS/article/view/57663acute intermittent porphyriaporphobilinogendepressionanxiety disorderspsychiatryplacebo
spellingShingle Waldemar Kosiba
Dominika Prystacka-Szar
Jakub Siemko
Wojciech Kupczak
Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
Journal of Education, Health and Sport
acute intermittent porphyria
porphobilinogen
depression
anxiety disorders
psychiatry
placebo
title Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
title_full Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
title_fullStr Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
title_full_unstemmed Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
title_short Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo
title_sort psychiatric symptoms in acute intermittent porphyria case report and course of treatment using placebo
topic acute intermittent porphyria
porphobilinogen
depression
anxiety disorders
psychiatry
placebo
url https://apcz.umk.pl/JEHS/article/view/57663
work_keys_str_mv AT waldemarkosiba psychiatricsymptomsinacuteintermittentporphyriacasereportandcourseoftreatmentusingplacebo
AT dominikaprystackaszar psychiatricsymptomsinacuteintermittentporphyriacasereportandcourseoftreatmentusingplacebo
AT jakubsiemko psychiatricsymptomsinacuteintermittentporphyriacasereportandcourseoftreatmentusingplacebo
AT wojciechkupczak psychiatricsymptomsinacuteintermittentporphyriacasereportandcourseoftreatmentusingplacebo